Table 1. Description of subjects.
HC (SD) | IBS (SD) | F | p value | Female IBS vs. female HC Effect size (es) Cohen's d | ||
---|---|---|---|---|---|---|
N | 137 | 73 | ||||
Bowel habit | ||||||
Constipation | 23 | |||||
Diarrhea | 21 | |||||
Alternating/mixed | 20 | |||||
Unspecified | 9 | |||||
Normal | 137 | 0 | ||||
Age | M = 28.62 (9.06) | M = 30.18 (9.43) | 1.37 | 0.24 | 0.17 | |
HAD anxiety | M = 3.25 (2.53) | M = 5.69 (3.62) | 4.21 | 0.04* | 0.83 | |
HAD depression | M = 1.19 (1.64) | M = 2.51 (2.35) | 21.89 | <0.001** | 0.69 | |
EAL (ETI) | ||||||
EAL prevalencea | 16 (12 %) | 16 (22 %) | 3.25 | 0.08 | ||
EAL total (sqrt) | M = 1.52 (1.07) | M = 1.89 (1.16) | 5.28 | 0.02* | 0.34 | |
EAL general | M = 1.35 (1.38) | M = 1.95 (1.72) | 1.17 | 0.28 | 0.40 | |
EAL physical | M = 0.97 (1.28) | M = 1.21 (1.40) | 1.80 | 0.18 | 0.18 | |
EAL emotional | M = 0.70 (1.30) | M = 1.23 (1.68) | 12.4 | 0.001** | 0.37 | |
EAL sexual | M = 0.40 (0.98) | M = 0.48 (1.14) | 0.96 | 0.33 | 0.08 | |
CT left sgACC (mm)b | M = 1.79 (0.39) | M = 1.64 (0.35) | 4.75 | 0.03* | –0.40 | |
CT right sgACC (mm)b | M = 1.69 (0.34) | M = 1.62 (0.40) | 0.84 | 0.36 | –0.20 | |
| ||||||
HC (SD) | IBS (SD) | χ2 | p value | Female IBS vs. female HC Effect size (es) Cohen's d | ||
| ||||||
Race | ||||||
African | 21 (15.3 %) | 10 (13.7 %) | ||||
Asian | 51 (37.2 %) | 18 (24.7%) | 5.17 | 0.16 | ||
Caucasian | 59 (43.1 %) | 43 (58.9 %) | ||||
Missing | 6 (4.3 %) | 2 (2.7 %) |
N number of subjects, M mean, SD standard deviation, es effect size (Cohen's d), IBS irritable bowel syndrome, HC healthy controls, Bowel Habit for IBS subjects based on ROME II/III diagnostic criteria, HAD Hospital Anxiety and Depression Scale, EAL early adverse life events, ETI early traumatic inventory (values square root), CT cortical thickness, sgACC subgenual anterior cingulate cortex, mm adjusted in millimeters
p < 0.05,
p < 0.01
EAL total scores ≥9
Controlled for age and total grey matter volume (TGMV)